KDIGO Bundle to Prevent AKI in Sepsis
Launched by HOSPITAL GENERAL UNIVERSITARIO ELCHE · Jan 7, 2020
Trial Information
Current as of July 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 18 years.
- • Patients (or their informed family members) who accept and sign the informed consent.
- • Patients diagnosed with sepsis or abdominal post-surgical septic shock.
- Exclusion Criteria:
- • Patients under 18 years.
- • Patients (or their authorized relatives) who refuse to sign the informed consent.
- • Patients diagnosed with sepsis or non-surgical septic shock.
- • Patients diagnosed with sepsis or septic shock of origin other than abdominal.
- • Patients with AKI stages KDIGO 2 and 3 and / or renal replacement therapy.
- • Patients with chronic renal failure and glomerular filtration \<30 ml / min and / or undergoing treatment with dialysis or previous renal transplantation.
- • Patients with AKI of origin other than the diagnosed septic, such as glomerulonephritis or interstitial nephritis, renal artery occlusion and / or postrenal obstruction.
About Hospital General Universitario Elche
Hospital General Universitario Elche is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. Located in Elche, Spain, the hospital is committed to improving patient outcomes through innovative studies and trials across various medical disciplines. With a multidisciplinary team of experienced healthcare professionals, the hospital fosters a collaborative environment that prioritizes patient safety and ethical standards. Its active involvement in clinical trials not only contributes to the advancement of medical knowledge but also enhances the standard of care available to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Elche, Alicante, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials